Ratings Boston Scientific Corporation

Equities

Market Closed - Nyse Other stock markets 21:01:54 17/06/2025 BST			5-day change	1st Jan Change
101.73 ^USD	+0.24%		+1.69%	+13.89%

06-16	Leerink Partners Initiates Boston Scientific at Outperform With $118 Price Target	MT
06-05	Bittium Enters ECG Monitoring Device Deal with Boston Scientific	MT

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company's MSCI ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

The company's profit outlook over the next few years is a strong asset.
The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
The company returns high margins, thereby supporting business profitability.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Analysts covering this company mostly recommend stock overweighting or purchase.

With an expected P/E ratio at 53.32 and 43.18 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Based on current prices, the company has particularly high valuation levels.
The company appears highly valued given the size of its balance sheet.
The valuation of the company is particularly high given the cash flows generated by its activity.

Source: Surperformance

Source: MSCI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Fundamentals (Composite)	Global Valuation (Composite)	Financial estimates revisions (Composite)	Capi.($)
	BOSTON SCIENTIFIC CORPORATION				150B
	INTUITIVE SURGICAL, INC.				186B
	THERMO FISHER SCIENTIFIC INC.				153B
	DANAHER CORPORATION				144B
	SIEMENS HEALTHINEERS AG				59.51B
	EDWARDS LIFESCIENCES CORPORATION				43.89B
	SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.				39.86B
	RESMED, INC.				36.84B
	AGILENT TECHNOLOGIES, INC.				33.81B
	GE HEALTHCARE TECHNOLOGIES INC.				33.36B
	Average				88.03B
	Weighted average by Cap.